Mayo Clinic in Arizona
Scottsdale, Arizona, 85259, United States
NCT Number: NCT07729384
This clinical trial tests the feasibility and acceptability of the Strengthening Teen Brain Resilience Using Music (STRUM) intervention to improve radiation induced cognitive decline for adolescents undergoing radiation therapy for cancer treatment. Adolescents treated with radiation therapy for cancer often experience persistent cognitive deficits and reduced brain resilience or the ability to preserve cognitive and emotional functioning despite stressors. Musical instrument training has been shown to enhance memory, academic skills, and emotional well-being in youth. Although guitars are often the most preferred instrument, ukuleles offer greater accessibility due to their simplicity, affordability, and suitability for younger users. The STRUM intervention consists of virtual active music therapy ukulele lessons, which may be a feasible and acceptable way to improve radiation induced cognitive decline for adolescents undergoing radiation therapy for cancer treatment.
Trial opening soon.
Get Notified12 year–17 year
All sexes
Interventional
Not applicable
Scottsdale, Arizona, 85259, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Ancillary studies
Attend STRUM sessions
Ancillary studies
Time frame: At time of enrollment
Feasibility defined as achieving a ≥ 70% consent rate among eligible participants.
Time frame: Up to 10 weeks
Participants will receive 10 weekly 30-minute virtual ukulele lessons over ten weeks. Basic descriptive statistical analyses will be performed.
Time frame: Up to 10 weeks
Assessed by patient self-report. Participants will be encouraged to practice their skills independently for at least 90 minutes per week. Basic descriptive statistical analyses will be performed.
Time frame: Baseline, week 6, week 12, week 20
Basic descriptive statistical analyses will be performed.
Time frame: Approximately 2 weeks following end of intervention (week 12)
Defined as mean Acceptability of Intervention Measure (AIM) score of ≥ 3/4, supported by exit interview feedback. Basic descriptive statistical analyses will be performed. The AIM is a study-specific measure that consists of 4 questions, each answered on a scale of 1 (completely disagree) to 5 (completely agree). Higher scores indicate greater acceptability.
Time frame: Approximately 2 weeks following end of intervention (week 12)
Assessed by exit interview feedback. Participants will complete semi-structured exit interviews (approximately 30-minute duration). Exit interview transcripts will be analyzed and coded using thematic analyses. Thematic findings will be used to refine the intervention design and delivery.
Time frame: Baseline, week 6, week 12, week 20
Assessed by cognitive testing using the BrainCheck Assess™ digital platform. Each testing session should take approximately 15 minutes. Standard aggregate scores range from 0-200 with lower scores generally suggesting greater cognitive impairment.
Contact information is provided by the study sponsor or research team.
Mayo Clinic
Other
Strengthening Teen Brain Resilience Using Music (STRUM) During Cancer Treatment: A Pilot Feasibility Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07412002
Childhood Hematopoietic and Lymphatic System Neoplasm, Childhood Malignant Solid Neoplasm
Oakland, California, United States
View Trial DetailsNCT06682039
Childhood Hematopoietic and Lymphatic System Neoplasm, Childhood Malignant Solid Neoplasm
Seattle, Washington, United States
View Trial DetailsNCT07737314
Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm
Seattle, Washington, United States
View Trial DetailsNCT07673614
Chemotherapy-induced Peripheral Neuropathy, Hematopoietic and Lymphatic System Neoplasm
Ann Arbor, Michigan, United States
View Trial Details